Additionally, we discovered that several polymorphisms might play important roles in the progression of HER2 enriched (ATG2B rs4900321 and rs7150025) and Luminal B (c-Kit rs2213181) early breast cancer. This evidence concerns the gene ATG2B and breast carcinoma.